<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">66125</article-id><article-id pub-id-type="doi">10.7554/eLife.66125</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>An open label trial of anakinra to prevent respiratory failure in COVID-19</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-211873"><name><surname>Kyriazopoulou</surname><given-names>Evdoxia</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9585-517X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220930"><name><surname>Panagopoulos</surname><given-names>Periklis</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-220931"><name><surname>Metallidis</surname><given-names>Symeon</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220932"><name><surname>Dalekos</surname><given-names>George N</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-220933"><name><surname>Poulakou</surname><given-names>Garyphallia</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-220934"><name><surname>Gatselis</surname><given-names>Nikolaos</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220935"><name><surname>Karakike</surname><given-names>Eleni</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221182"><name><surname>Saridaki</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220937"><name><surname>Loli</surname><given-names>Georgia</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220938"><name><surname>Stefos</surname><given-names>Aggelos</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220939"><name><surname>Prasianaki</surname><given-names>Danai</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220940"><name><surname>Georgiadou</surname><given-names>Sarah</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220941"><name><surname>Tsachouridou</surname><given-names>Olga</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220942"><name><surname>Petrakis</surname><given-names>Vasileios</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220943"><name><surname>Tsiakos</surname><given-names>Konstantinos</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220944"><name><surname>Kosmidou</surname><given-names>Maria</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8618-9435</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220945"><name><surname>Lygoura</surname><given-names>Vassiliki</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220946"><name><surname>Dareioti</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220947"><name><surname>Milionis</surname><given-names>Haralampos</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-220948"><name><surname>Papanikolaou</surname><given-names>Ilias C</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-196636"><name><surname>Akinosoglou</surname><given-names>Karolina</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220949"><name><surname>Myrodia</surname><given-names>Dimitra-Melia</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220950"><name><surname>Gravvani</surname><given-names>Areti</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220951"><name><surname>Stamou</surname><given-names>Aliki</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220952"><name><surname>Gkavogianni</surname><given-names>Theologia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220953"><name><surname>Katrini</surname><given-names>Konstantina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220954"><name><surname>Marantos</surname><given-names>Theodoros</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220955"><name><surname>Trontzas</surname><given-names>Ioannis P</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220956"><name><surname>Syrigos</surname><given-names>Konstantinos</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220957"><name><surname>Chatzis</surname><given-names>Loukas</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2832-0116</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221183"><name><surname>Chatzis</surname><given-names>Stamatios</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220959"><name><surname>Vechlidis</surname><given-names>Nikolaos</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220960"><name><surname>Avgoustou</surname><given-names>Christina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220961"><name><surname>Chalvatzis</surname><given-names>Stamatios</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220962"><name><surname>Kyprianou</surname><given-names>Miltiades</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-41027"><name><surname>van der Meer</surname><given-names>Jos WM</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-220963"><name><surname>Eugen-Olsen</surname><given-names>Jesper</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" id="author-215698"><name><surname>Netea</surname><given-names>Mihai G</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="conf8"/></contrib><contrib contrib-type="author" corresp="yes" id="author-140454"><name><surname>Giamarellos-Bourboulis</surname><given-names>Evangelos J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4713-3911</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf9"/></contrib><aff id="aff1"><institution content-type="dept">4th Department of Internal Medicine</institution>, <institution>National and Kapodistrian University of Athens, Medical School</institution>, <addr-line><named-content content-type="city">Athens</named-content></addr-line>, <country>Greece</country></aff><aff id="aff2"><institution content-type="dept">2nd Department of Internal Medicine</institution>, <institution>Democritus University of Thrace, Medical School</institution>, <addr-line><named-content content-type="city">Alexandroupolis</named-content></addr-line>, <country>Greece</country></aff><aff id="aff3"><institution content-type="dept">1st Department of Internal Medicine</institution>, <institution>Aristotle University of Thessaloniki, Medical School</institution>, <addr-line><named-content content-type="city">Thessaloniki</named-content></addr-line>, <country>Greece</country></aff><aff id="aff4"><institution content-type="dept">Department of Medicine and Research Laboratory of Internal Medicine</institution>, <institution>National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa</institution>, <addr-line><named-content content-type="city">Larissa</named-content></addr-line>, <country>Greece</country></aff><aff id="aff5"><institution content-type="dept">3rd Department of Internal Medicine</institution>, <institution>National and Kapodistrian University of Athens, Medical School</institution>, <addr-line><named-content content-type="city">Athens</named-content></addr-line>, <country>Greece</country></aff><aff id="aff6"><institution content-type="dept">1st Department of Internal Medicine</institution>, <institution>Univeristy of Ioannina School of Medicine</institution>, <addr-line><named-content content-type="city">Ioannina</named-content></addr-line>, <country>Greece</country></aff><aff id="aff7"><institution content-type="dept">1st Department of Internal Medicine</institution>, <institution>University of Ioannina, School of Health Sciences, Faculty of Medicine</institution>, <addr-line><named-content content-type="city">Ioannina</named-content></addr-line>, <country>Greece</country></aff><aff id="aff8"><institution content-type="dept">Department of Pulmonary Medicine</institution>, <institution>General Hospital of Kerkyra</institution>, <addr-line><named-content content-type="city">Corfou</named-content></addr-line>, <country>Greece</country></aff><aff id="aff9"><institution>University of Patras</institution>, <addr-line><named-content content-type="city">Rion</named-content></addr-line>, <country>Greece</country></aff><aff id="aff10"><institution content-type="dept">Internal Medicine</institution>, <institution>Radboud University Medical Centre</institution>, <addr-line><named-content content-type="city">Nijmegen</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff11"><institution content-type="dept">Clinical Research Centre</institution>, <institution>Copenhagen University Hospital Hvidovre</institution>, <addr-line><named-content content-type="city">Copenhagen</named-content></addr-line>, <country>Denmark</country></aff><aff id="aff12"><institution content-type="dept">Internal Medicine</institution>, <institution>Radboud University Nijmegen Medical Centre</institution>, <addr-line><named-content content-type="city">Nijmegen</named-content></addr-line>, <country>Netherlands</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-149979"><name><surname>Mangoni</surname><given-names>Arduino A</given-names></name><role>Reviewing editor</role><aff><institution>Flinders Medical Centre</institution>, <country>Australia</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>egiamarel@med.uoa.gr</email> (EG);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>08</day><month>03</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e66125</elocation-id><history><date date-type="received"><day>29</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>04</day><month>03</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Kyriazopoulou et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Kyriazopoulou et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-66125-v1.pdf"/><abstract><p><bold>Background</bold> It was studied if early suPAR-guided anakinra treatment can prevent severe respiratory failure (SRF) of COVID-19.</p><p><bold>Methods</bold> 130 patients with suPAR ≥6 ng/ml were assigned to subcutaneous anakinra 100mg once daily for 10 days. Primary outcome was SRF incidence by day 14 defined as any respiratory ratio below 150 mmHg necessitating mechanical or non-invasive ventilation. Main secondary outcomes were 30-day mortality and inflammatory mediators; 28-day WHO-CPS was explored. Propensity-matched standard-of care comparators were studied.</p><p><bold>Results</bold> 22.3% with anakinra treatment and 59.2% comparators (hazard ratio, 0.30; 95%CI, 0.20-0.46) progressed into SRF; 30-day mortality was 11.5% and 22.3% respectively (hazard ratio 0.49; 95% CI 0.25-0.97). Anakinra was associated with decrease in circulating interleukin (IL)-6, sCD163 and sIL2-R; IL-10/IL-6 ratio on day 7 was inversely associated with SOFA score; patients were allocated to less severe WHO-CPS strata.</p><p><bold>Conclusions</bold> Early suPAR-guided anakinra decreased SRF and restored the pro-/anti-inflammatory balance.</p><p><bold>Trial Registration:</bold> ClinicalTrials.gov, NCT04357366</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Hellenic Institute for the Study of Sepsis</institution></institution-wrap></funding-source><award-id>NA</award-id><principal-award-recipient><name><surname>Giamarellos-Bourboulis</surname><given-names>Evangelos J</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Technomar Shipping Inc</institution></institution-wrap></funding-source><award-id>NA</award-id><principal-award-recipient><name><surname>Giamarellos-Bourboulis</surname><given-names>Evangelos J</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Swedish Orphan Biovitrum AB</institution></institution-wrap></funding-source><award-id>NA</award-id><principal-award-recipient><name><surname>Giamarellos-Bourboulis</surname><given-names>Evangelos J</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Horizon 2020</institution></institution-wrap></funding-source><award-id>RISKinCOVID</award-id><principal-award-recipient><name><surname>Giamarellos-Bourboulis</surname><given-names>Evangelos J</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Periklis Panagopoulos, honoraria from GILEAD Sciences, Janssen, and MSD.</p></fn><fn fn-type="conflict" id="conf3"><p>George N Dalekos, Advisor/Lecturer for Abbvie, Bristol-Myers Squibb, Gilead, Novartis, Roche, Amgen, MSD, Janssen, Ipsen and Pfizer, has received Grant support from Bristol-Myers Squib, Gilead, Roche, Janssen, Abbvie and Bayer and was or is currently PI in National &amp; International Protocols sponsored by Abbvie, Bristol-Myers Squibb, Novartis, Gilead, Novo Nordisk, Genkyotex, Regulus Therapeutics Inc, Tiziana Life Sciences, Bayer, Astellas, Ipsen, Pfizer and Roche.</p></fn><fn fn-type="conflict" id="conf4"><p>Garyphallia Poulakou, independent educational grants from Pfizer, MSD, Angelini, and Biorad.</p></fn><fn fn-type="conflict" id="conf5"><p>Haralampos Milionis, honoraria, consulting fees and non-financial support from healthcare companies, including Amgen, Angelini, Bayer, Mylan, MSD, Pfizer, and Servier.</p></fn><fn fn-type="conflict" id="conf6"><p>Jos WM van der Meer, Senior editor, <italic>eLife</italic>.</p></fn><fn fn-type="conflict" id="conf7"><p>Jesper Eugen-Olsen, cofounder, shareholder and CSO of ViroGates A7S, Denmark and is named inventor on patents on suPAR owned by Copenhagen University Hospital Hvidovre, Denmark.</p></fn><fn fn-type="conflict" id="conf8"><p>Mihai G Netea, supported by an ERC Advanced Grant (#833247) and a Spinoza grant of the Netherlands Organization for Scientific Research. He has also received independent educational grants from TTxD, GSK and ViiV HealthCare.</p></fn><fn fn-type="conflict" id="conf9"><p>Evangelos J Giamarellos-Bourboulis, Reviewing editor, <italic>eLife</italic>honoraria from Abbott CH, Angelini Italy, InflaRx GmbH, MSD Greece, XBiotech Inc., and B·R·A·H·M·S GmbH (Thermo Fisher Scientific); independent educational grants from AbbVie Inc, Abbott CH, Astellas Pharma Europe, AxisShield, bioMérieux Inc, Novartis, InflaRx GmbH, and XBiotech Inc; and funding from the FrameWork 7 program HemoSpec (granted to the National and Kapodistrian University of Athens), the Horizon2020 Marie-Curie Project European Sepsis Academy (granted to the National and Kapodistrian University of Athens), and the Horizon 2020 European Grant ImmunoSep (granted to the Hellenic Institute for the Study of Sepsis)..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Approved in Greece by National Ethics Committee approval 38/20; National Organization for Medicines approval ISO 28/20.Written informed consent was provided by the patient or legal representative before screening.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Data of this submission are anticipated to be part of a submission package to the European Medicines Agency for the request of approval of Anakinra for the management of COVID-19 guided by the biomarker suPAR. Once this is finalized, the data will be made publicly available upon request. Requests will require signing contract with the sponsor of the study which is the Hellenic Institute for the Study of Sepsis. The responsible official is Ms Leda Efstratiou who is the DPO responsible for GDPR. Interested researchers should contact Ms Efstratiou at le.efstrat@gmail.com and headed@sepsis.gr to request access to the data.</p></sec><supplementary-material><ext-link xlink:href="elife-66125-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>